NCT05830084
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05830084
Title Phase Ib / Regorafenib With Conventional Chemotherapy/Newly Diagnosed Patients/ Multimetastatic Ewing Sarcoma (REGO-EWING)
Acronym REGO-EWING
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Gustave Roussy, Cancer Campus, Grand Paris
Indications
Therapies
Age Groups: adult | child
Covered Countries NLD | ITA | FRA | ESP | DNK | AUS

Facility Status City State Zip Country Details
Queensland Children's Hospital ACTIVE_NOT_RECRUITING Brisbane Australia Details
Monash Children's Hospital RECRUITING Clayton Australia Details
Royal Children's Hospital RECRUITING Parkville Australia Details
Perth Children's Hospital ACTIVE_NOT_RECRUITING Perth WA6009 Australia Details
Rigshospitalet ACTIVE_NOT_RECRUITING Copenhagen DK-2100 Denmark Details
CHU Bordeaux RECRUITING Bordeaux France Details
Centre Oscar Lambret RECRUITING Lille France Details
centre Léon Bérard RECRUITING Lyon France Details
Institut Curie RECRUITING Paris France Details
Gustave Roussy RECRUITING Villejuif Île-de-France Region 94805 France Details
Istituto Nazionale dei Tumori ACTIVE_NOT_RECRUITING Milan 20133 Italy Details
Princess Máxima Center RECRUITING Utrecht 113 Netherlands Details
Vall d'Hebron University Hospital ACTIVE_NOT_RECRUITING Barcelona 119-12 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field